GSK 576389A

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGSK 576389A

Drug Alias NameFluAS25 adjuvanted influenza vaccine - GlaxoSmithKlineSeasonal influenza virus vaccine - GlaxoSmithKlineFluAS25 adjuvanted inluenza vaccine - GlaxoSmithKlineGSK576389AGSK-576389A

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A